Trials / Completed
CompletedNCT05440006
A Study of Food Effect on the Pharmacokinetics of Fuzuloparib Capsules in Chinese Healthy Adult Subjects
Randomized, Open, Two Cycle, Two Sequence, Cross Reference Designed Study on the Effect of Food on the Pharmacokinetics of Fuzuloparib Capsules in Chinese Healthy Adult Subjects
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 20 (actual)
- Sponsor
- Jiangsu HengRui Medicine Co., Ltd. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
The objective of the study is to assess the effect of food on the pharmacokinetics, and safety of Fuzuloparib Capsules in healthy subject.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Fuzuloparib | Fuzuloparib Capsules; 150mg; single dose per cycle. |
Timeline
- Start date
- 2022-07-03
- Primary completion
- 2022-07-20
- Completion
- 2022-07-20
- First posted
- 2022-06-30
- Last updated
- 2022-09-08
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT05440006. Inclusion in this directory is not an endorsement.